| Application no. and date | 11847198.6 (espacenet) (Federated) (European Patent Register), 20111206 | | Patent/reg. no. and date | DK/EP 2648752, 20170215 | | Publication date | 20131016 | | Priority no. and date | US 420291 P, 20101206, US 201161446990 P, 20110225 | | EP pub. no. and date |
EP 2648752 20131016 | | Effective date | | | Applicant/owner | SEAGEN INC., 21823 30th Drive, S.E.
Bothell, WA 98021, US | | Applicant ref. no. | V441DKEP | | Inventor | SMITH, Maria Leia, 21823 30th Drive S.E.
Bothell
Washington 98021, US,
SUSSMAN, Django, 21823 30th Drive S.E.
Bothell
Washington 98021, US,
ARTHUR, William, 21823 30th Drive S.E.
Bothell
Washington 98021, US,
NESTEROVA, Albina, 21823 30th Drive S.E.
Bothell
Washington 98021, US | | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | | Opponent | | | IPC Class | A61K 35/00 (2006.01) , A61K 39/395 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C12P 21/08 (2006.01) | | Title | HUMANISEREDE ANTISTOFFER MOD LIV-1 OG ANVENDELSE DERAF TIL BEHANDLING AF CANCER | | Int. application no. | US2011063612 | | Int. publication no. | WO2012078688 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
